Cannabis stocks jumped in Friday's premarket activity after the Washington Post reported that US President Donald Trump seeks to "dramatically loosen" restrictions on marijuana. Trump intends to direct his government to ease restrictions on the marijuana plant and its derivatives, and reclassify it as a Schedule III drug, placing it on the same level as regular prescription painkillers. Our proprietary real time alert services picked up CGC's unusual stock and option volume F

Cannabis stocks were up in trading Tuesday after the Associated Press reported that the US Drug Enforcement Administration planned to...

The release of documents that support a recommendation by the U.S. Department of Health and Human Services to lower the classification of...